MVIR — Medivir AB Balance Sheet
0.000.00%
- SEK52.60m
- SEK29.10m
- SEK3.48m
Annual balance sheet for Medivir AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 70 | 221 | 117 | 170 | 62.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.99 | 2.74 | 2.83 | 7.22 | 2.93 |
| Prepaid Expenses | |||||
| Total Current Assets | 78.9 | 226 | 123 | 179 | 66.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 16.2 | 13.6 | 14.8 | 12.4 | 9.63 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 191 | 336 | 234 | 288 | 173 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 34.7 | 41.7 | 28 | 58.7 | 48.5 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 49.6 | 54.7 | 41.4 | 70 | 57.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 142 | 281 | 193 | 218 | 116 |
| Total Liabilities & Shareholders' Equity | 191 | 336 | 234 | 288 | 173 |
| Total Common Shares Outstanding |